______________________________

Statistics: COVID-19 Data

_____________________________

Abstract

In amidst of epidemic virus outbreak globally, preconceived data and intricacies of the
underlying principles pose significant difficulties in statistically presenting and composing a
framework for the outbreak of the COVID-19. By the effort of the international community and
local community as a response to the early stage of the pandemic, statistics were able to serve
as a toolkit in providing necessary data in showing the numbers of the infected population in
particular territories globally to be directly accessible in data and information to the global
citizen to coordinate in analyzing the outbreak stages and accessing interventions throughout
the international group and community in fighting Novel Corona Virus.

Introduction

Novel Corona Virus, also known as COVID-19, is subsequently named SARS-CoV-2, in

which the first case is officially reported in the wholesale food market of Wuhan City, China, in
December last year. With the early outbreak of the virus in the city, the market was closed on
January 1, 2020. In the early outbreak stage of the coronavirus, it was uncontrollable
transmission in China until the virus took international borders and drastically increasing the
cases of COVID-19 in different regions across the globe. The travel ban of international flight
takes place, intensified enhance community quarantine, physical distancing, mandatory
facemask, expanded taskforce in contact tracing, preventative actions, and stringent policies
implemented as an immediate response to the COVID-19 outbreak in the early stage in other
countries.
 As of now, the epicenter of the COVID-19 is in the Americas, with 27,754,113 confirmed
cases of COVID-19 as of 11:08 AM CET, December 5, 2020. Its been a year since the COVID-19
drastically emerged across the international borders and WHO is responsively taking
intervention in fighting COVID-19. Essentially, the utilization of statistical epidemiology and
biostatistics in finding vaccine towards COVID-19 is relevantly playing a vital role in health
research and part of clinical medicine. Recently, the world’s largest pharmaceutical company-
Pfizer is officially announced the primary efficacy analysis of BNT162b2 to be 95% effective
against COVID-19. With the research studies and clinical trials of Pfizer and BioNTech is officially
approved as the First Authorization in the World for a Vaccine to Combat COVID-19 and Pfizer
Inc.

Undeniably, the world is struggling with the infectious COVID-19 pandemic. Almost half
of the world's population is already affected, and cases and deaths of the COVID-19 remain
increasing; as of 11:08 AM CET, December 5, 2020, there have been 65,007,974 confirmed
cases of COVID-19, including 1,507,018 deaths in 220 countries around the globe, reported to
World Health Organization(WHO). Conclusively, with the macro effort of international
communities and standardized institutions taking an intervention such as finding vaccine as the
principal objective and creating stringent policies as guidance for the government units and
preventive actions in fighting COVID-19. Indeed, every data is counts as a matter regarding
COVID-19 as it will be feasible to intensify and enhance existing policies in flattening the curve
and recuperate the infected territories globally.

Scope

The study covered the six continents in the world that are severely affected by the COVID-19
pandemic, namely, Americas, Europe, Southeast Asia, Eastern Mediterranean, Africa, and
Western Pacific. In a particular region, there are some free COVID-19 countries. However, the
data does not imply that the COVID-19 infects the entire population in the region. However, the
total data in the region is composed of different countries that are reportedly confirmed the
numbers of COVID-19 cases in a particular area in the region.
 Discussion

Global Situation

Figure 1: Global Situation of COVID-19 Data of confirmed cases. Retrieved from: https://covid19.who.int/

Figure 2: Global Situation of COVID-19 Data of deaths. Retrieved from: https://covid19.who.int/

Note: The Data was taken at 11:08 AM, December 5, 2020. The current data is outdated now due to continuous updates of WHO. The updates of current data are available on the WHO official website.

Confirmed Cases
World Health Organization dashboard is responsively updating every hour for necessary
publication and transparency into the international community. Figure 1 shows the Global Data
of COVID-19 that there have been 65,257,767 confirmed cases, including the deaths report
data. The timeline illustrates the drastic increase in confirmed cases from January to the
present time. Furthermore, the WHO recorded on November 14, 2020, the highest confirmed
cases globally, with 667,968 positive cases. 

Deaths
A massive death report data on COVID-19 was being recorded periodically as a means of
transparency and updates to everyone across the globe. Figure 2 shows the Global Data of
COVID-19 that 1,513,179 positive cases died due to COVID-19. The timeline illustrates the
dynamic of the COVID-19 deaths report data. The WHO recorded on April 17, 2020, the highest
data of deaths with 12,510 deaths on COVID-19.
 Situation of WHO Region Confirmed
Cases

Figure 3: Situation by WHO Region of COVID-19 Data of confirmed cases. Retrieved from: https://covid19.who.int/
Note: The Data was taken at 11:08 AM, December 5, 2020. The current data is outdated now due to continuous updates of WHO. The updates of current data are available on the WHO official website.

Confirmed Cases
The massive outbreak of COVID-19 is uncontrollably transmuted to the international borders
due to travel history and physical contact to the COVID-19 positive. The rapid dispersal and
contagious characteristic of the virus is the dominant factor in the drastic increase of positive
cases in the different regions across the globe. Figure 3 depicts the COVID-19 data in the
different regions in which the Americas' region is the highest recorded data with 27,754,113
COVID-19 confirmed cases. Europe's region marks as second-highest recorded data with
19,775,465 COVID-19 confirmed cases. Southeast Asia's region marks as third-highest recorded
data with 11,023,450 COVID-19 confirmed cases. Eastern Mediterenian's region marks as
fourth-highest recorded data with 4,256,386 COVID-19 confirmed cases. The African region
marks as the fifth-highest recorded data with 1,538,949 COVID-19 confirmed cases, and the
Western Pacific region was identified as the lowest recorded data with 908,663 COVID-19
confirmed cases.
 Situation of WHO Region
Deaths

Figure 4: Situation by WHO Region of COVID-19 Data of deaths. Retrieved from: https://covid19.who.int/
Note: The Data was taken at 11:08 AM, December 5, 2020. The current data is outdated now due to continuous updates of WHO. The updates of current data are available on the WHO official website.

Deaths
The COVID-19 pandemic brought a sudden change in the global community and created "new
normals" in society. As of now, about half of the world is infected by the virus, and tragically
the deaths of COVID-19 are in total of 1,513,179 cases. Figure 4 depicts the COVID-19 data in
different regions in which the total deaths of COVID-19 is the same as the order in the
confirmed cases of COVID-19, in which Americas' region is also the highest fatality rate in
COVID-19, followed by Europe's region as the second-highest fatality rate in COVID-19,
Southeast Asia's region as the third-highest fatality rate in COVID-19, Eastern Mediterranean's
region as fourth-highest fatality rate in COVID-19, Africa as the fifth-highest fatality rate in
COVID-19 and Western Pacific region as the lowest fatality rate in COVID-19. Thereupon, even
the first world country in the America's region, got infected by the virus, particularly USA. The
fatality rate of the COVID-19 remains drastically increasing as the confirmed cases are
increasing relatively because of the dense population of the Americas and unrestricted people's
movement where spatial closeness takes place that makes the virus contagious and vulnerable
and yet the healthcare system of the country doesn’t vary as an advantage because the region
remains as the epicenter of the COVID-19 as of now.
Recommendation
 The COVID-19 virus remains stable at increasing confirmed cases with no signs of
slowing the cumulative total data periodically, and weekly deaths report continues to
rise. With the drastic rising data of confirmed cases, America's region must oblige to
enhance mechanisms to physically limit social interaction and integrate counterparts
from national, regional, and locally confirmed cases. America's region has a dense
population that one of the factors that imply a drastic increase in COVID-19 cases. The
COVID-19 virus is contagious in a way that spatial closeness makes the virus vulnerable.
International, regional, and local government units must stringently enforce the WHO
organization as the framework will guide and set the signs of slowing the contagious
virus's aggression (COVID-19). The other region should do the same as the virus is
vulnerable in the dense population.  
 The global community must assess the current preparedness and response measures of
designated regions or jurisdictions. Dedicating substantial resources management to
public health parameters should educate the public for their own awareness and
literacy toward the virus. It is simple but quite beneficial in endowing awareness to the
public to enable the community's coordination in fighting COVID-19. 
 Stringently enforcing to stop the people's movement requires social and physical
interaction where spatial closeness occurs. Unfortunately, the economies of the
countries have negative impacts in disrupting trade and transactions of the industries.
However, this simply making the virus invulnerable due to non-contact transmission. 
 Infection prevention action and control are essential frameworks to ensure healthcare
workers' safety or medical front liners and civilians. The virus is more vulnerable in
countries that have poor health care systems and a dense population. National
authorities should fund development research and innovation instead of continuing
unnecessary national projects that do not benefit the country. Expanding national
authorities' efforts by preparing instant access to laboratory diagnostic, therapeutics,
and vaccine trials as a primal objective.
Conclusion

The world's unforeseen enemy is dominating half of life across the globe, and people of
the world are anxious about the current dilemmas that the world faces right now. This is a
challenge to the global community to adhere to the oneness and solidarity to solve the Novel
Coronavirus's difficulties and gaps. It’s been a year since COVID-19 outbreaks start, and global
communities are continuously responding to the contagious virus (COVID-19). As of now, the
global community's effort suddenly yields the pandemic, and principal objectives such as
finding a vaccine for COVID-19 to flatten the curve is now in the hand of the international
community particularly Pfizer.

During this pandemic, numbers and data are counts as a matter as it gives us the
probability to have a result with regards to finding an answer and response to the unforeseen
enemy (COVID-19). In academe, statistics taught the proper analysis of data beyond that
insight; statistics are significantly quantifying the probability of success and failure or yes and no
by setting benchmarks or standards. It is the framework of the potential growth and viability of
certain subjects using statistical data. 

Indeed, the usage of statistics in epidemiology is distinctively significant in the process

of finding an answer and response to the pandemic. The probability of success and failure
during this pandemic is fated in the hands of scientific studies, methodologies, and frameworks,
as it is retaliating conspiring theories that are continuously propagating in the absence of
scientific basis and evidence. Data and Numbers are quite an arbiter; merely human lives
always matter! 
References

Inc., P. (2020, December 02). Pfizer. Retrieved from ALL COVID-19 UPDATES:
https://www.pfizer.com/health/coronavirus/updates
Inc., P. (2020, November 18). Pfizer. Retrieved from PFIZER AND BIONTECH CONCLUDE PHASE 3
STUDY OF COVID-19 VACCINE CANDIDATE, MEETING ALL PRIMARY EFFICACY
ENDPOINTS: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-
and-biontech-conclude-phase-3-study-covid-19-vaccine
Shane Pascoe. (2012). Introduction. In G. Law, Statistical Epidemiology (p. 08). UK: CABI
Bookshop.
WHO. (2020). Timeline: WHO's COVID-19 response. Retrieved from World Health Organization:
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-
timeline?gclid=CjwKCAiA_Kz-
BRAJEiwAhJNY7ykNE_oDaZ7uuoPwxv45jTkgcCtSfhis1byEF8Anp1pv-
cDeLOdnthoCuggQAvD_BwE#event-0
WHO. (2020, December 05). WHO Coronavirus Disease (COVID-19) Dashboard. Retrieved from
World Health Organization: https://covid19.who.int/
WHO. (2020, April 23). World Health Organization. Infection prevention and control during
health care when COVID-19 is suspected. Retrieved from World Health Organization:
https://www.who.int/publications-detail/infection-prevention-and-control-during-
health-care-when-novel-coronavirus-(ncov)-infection-is-suspected-20200125
WHO. (n.d.). World Health Organization. Retrieved from Health statistics:
https://www.who.int/topics/statistics/en/
WHO. (2020, December 05). WHO Coronavirus Disease (COVID-19) Dashboard. Retrieved from
World Health Organization: https://covid19.who.int/